Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $5.13 in the prior trading day, Aptevo Therapeutics Inc (NASDAQ: APVO) closed at $2.31M, up 3225695%. In other words, the price has increased by $3225695 from its previous closing price. On the day, 3.23 million shares were traded. APVO stock price reached its highest trading level at $5.0799 during the session, while it also had its lowest trading level at $3.82.
Ratios:
Our goal is to gain a better understanding of APVO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 0.67.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 2814750 and an Enterprise Value of 3973789.
Stock Price History:
The Beta on a monthly basis for APVO is 5.73, which has changed by -0.9895258 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, APVO has reached a high of $485.37, while it has fallen to a 52-week low of $2.81. The 50-Day Moving Average of the stock is -53.00%, while the 200-Day Moving Average is calculated to be -95.60%.
Shares Statistics:
The stock has traded on average 2.31M shares per day over the past 3-months and 12850900 shares per day over the last 10 days, according to various share statistics. Insiders hold about 0.00% of the company’s shares, while institutions hold 0.17% stake in the company. Shares short for APVO as of 1748563200 were 9397 with a Short Ratio of 0.00, compared to 1745971200 on 22613. Therefore, it implies a Short% of Shares Outstanding of 9397 and a Short% of Float of 1.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
